Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered
• 1.4 Market Analysis by Type
  • 1.4.1 Global Entereg (alvimopan) Market Size Growth Rate by Type (2014-2025)
  • 1.4.2 12 mg Capsule
  • 1.4.3 Type II
• 1.5 Market by Application
  • 1.5.1 Global Entereg (alvimopan) Market Share by Application (2014-2025)
  • 1.5.2 Partial bowel resection
  • 1.5.3 Radical cystectomy
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Entereg (alvimopan) Market Size
• 2.2 Entereg (alvimopan) Growth Trends by Regions
  • 2.2.1 Entereg (alvimopan) Market Size by Regions (2014-2025)
  • 2.2.2 Entereg (alvimopan) Market Share by Regions (2014-2019)
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Opportunities

3 Market Share by Key Players

• 3.1 Entereg (alvimopan) Market Size by Manufacturers
  • 3.1.1 Global Entereg (alvimopan) Revenue by Manufacturers (2014-2019)
  • 3.1.2 Global Entereg (alvimopan) Revenue Market Share by Manufacturers (2014-2019)
  • 3.1.3 Global Entereg (alvimopan) Market Concentration Ratio (CR5 and HHI)
• 3.2 Entereg (alvimopan) Key Players Head office and Area Served
• 3.3 Key Players Entereg (alvimopan) Product/Solution/Service
• 3.4 Date of Enter into Entereg (alvimopan) Market
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

• 4.1 Global Entereg (alvimopan) Market Size by Type (2014-2019)
• 4.2 Global Entereg (alvimopan) Market Size by Application (2014-2019)

5 United States

• 5.1 United States Entereg (alvimopan) Market Size (2014-2019)
• 5.2 Entereg (alvimopan) Key Players in United States
• 5.3 United States Entereg (alvimopan) Market Size by Type
• 5.4 United States Entereg (alvimopan) Market Size by Application

6 Europe

• 6.1 Europe Entereg (alvimopan) Market Size (2014-2019)
• 6.2 Entereg (alvimopan) Key Players in Europe
• 6.3 Europe Entereg (alvimopan) Market Size by Type
• 6.4 Europe Entereg (alvimopan) Market Size by Application

7 China

• 7.1 China Entereg (alvimopan) Market Size (2014-2019)
• 7.2 Entereg (alvimopan) Key Players in China
• 7.3 China Entereg (alvimopan) Market Size by Type
• 7.4 China Entereg (alvimopan) Market Size by Application

8 Japan

• 8.1 Japan Entereg (alvimopan) Market Size (2014-2019)
• 8.2 Entereg (alvimopan) Key Players in Japan
• 8.3 Japan Entereg (alvimopan) Market Size by Type
• 8.4 Japan Entereg (alvimopan) Market Size by Application

9 Southeast Asia

• 9.1 Southeast Asia Entereg (alvimopan) Market Size (2014-2019)
• 9.2 Entereg (alvimopan) Key Players in Southeast Asia
• 9.3 Southeast Asia Entereg (alvimopan) Market Size by Type
• 9.4 Southeast Asia Entereg (alvimopan) Market Size by Application

10 India

• 10.1 India Entereg (alvimopan) Market Size (2014-2019)
• 10.2 Entereg (alvimopan) Key Players in India
• 10.3 India Entereg (alvimopan) Market Size by Type
• 10.4 India Entereg (alvimopan) Market Size by Application

11 Central & South America

• 11.1 Central & South America Entereg (alvimopan) Market Size (2014-2019)
• 11.2 Entereg (alvimopan) Key Players in Central & South America
• 11.3 Central & South America Entereg (alvimopan) Market Size by Type
• 11.4 Central & South America Entereg (alvimopan) Market Size by Application

12 International Players Profiles

• 12.1 Merck
  • 12.1.1 Merck Company Details
  • 12.1.2 Company Description and Business Overview
  • 12.1.3 Entereg (alvimopan) Introduction
  • 12.1.4 Merck Revenue in Entereg (alvimopan) Business (2014-2019)
  • 12.1.5 Merck Recent Development

13 Market Forecast 2019-2025

• 13.1 Market Size Forecast by Regions
• 13.2 United States
• 13.3 Europe
• 13.4 China
• 13.5 Japan
• 13.6 Southeast Asia
• 13.7 India
• 13.8 Central & South America
• 13.9 Market Size Forecast by Product (2019-2025)
• 13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 12.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Disclaimer

Entereg (alvimopan) is the first and only FDA-approved agent indicated to accelerate the time to gastrointestinal (GI) recovery following surgeries that include partial bowel resection with primary anastomosis.
In 2018, the global Entereg (alvimopan) market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Entereg (alvimopan) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Entereg (alvimopan) development in United States, Europe and China.

The key players covered in this study
Merck
...

Market segment by Type, the product can be split into
12 mg Capsule
Type II

Market segment by Application, split into
Partial bowel resection
Radical cystectomy

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Entereg (alvimopan) status, future forecast, growth opportunity, key market and key players.
To present the Entereg (alvimopan) development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Entereg (alvimopan) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.